Search hospitals > New Jersey > Ridgewood
Valley Hospital
Claim this profileRidgewood, New Jersey 07450
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Atrial Fibrillation
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
254 reported clinical trials
16 medical researchers
Summary
Valley Hospital is a medical facility located in Ridgewood, New Jersey. This center is recognized for care of Breast Cancer, Cancer, Atrial Fibrillation, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Valley Hospital is involved with conducting 254 clinical trials across 262 conditions. There are 16 research doctors associated with this hospital, such as Eleonora Teplinsky, MD, Suneet Mittal, Jason Suh, and Kevin C. Wood.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Cancer
Global LeaderStage III
Stage IV
Stage II
Top PIs
Eleonora Teplinsky, MDThe Valley Hospital-Luckow Pavilion4 years of reported clinical research
Studies Breast Cancer
Studies Cancer
13 reported clinical trials
28 drugs studied
Suneet MittalThe Valley Hospital2 years of reported clinical research
Studies Heart Failure
Studies Atrial Fibrillation
7 reported clinical trials
9 drugs studied
Jason SuhThe Valley Hospital-Luckow Pavilion5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
6 reported clinical trials
18 drugs studied
Kevin C. WoodThe Valley Hospital-Luckow Pavilion2 years of reported clinical research
Studies Tumors
Studies Pancreatic Cancer
6 reported clinical trials
12 drugs studied
Clinical Trials running at Valley Hospital
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Bladder Cancer
Cancer
Breast Cancer
Aortic Valve Stenosis
Pancreatic Cancer
Colorectal Cancer
Multiple Myeloma
Dato-DXd + Pembrolizumab
for Advanced Lung Cancer
This study is designed to assess the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab versus pembrolizumab alone in participants with advanced or metastatic non-small cell lung cancer (NSCLC).
Recruiting2 awards Phase 313 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Valley Hospital?
Valley Hospital is a medical facility located in Ridgewood, New Jersey. This center is recognized for care of Breast Cancer, Cancer, Atrial Fibrillation, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Valley Hospital is involved with conducting 254 clinical trials across 262 conditions. There are 16 research doctors associated with this hospital, such as Eleonora Teplinsky, MD, Suneet Mittal, Jason Suh, and Kevin C. Wood.